Categories
October Surprise 2024

FGFR and Biomarker Testing | BALVERSAĀ® (erdafitinib) HCP

Learn how FGFR biomarker testing helps identify patients with metastatic urothelial carcinoma who are eligible for BALVERSAĀ®. See Full Safety and Prescribing Information.